Natasa Nestorovic

Dr. Natasa Nestorovic

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
BBBiljana N. Bursać
Biljana N. Bursać
AVAna D. Vasiljević
Ana D. Vasiljević
NNNatasa Nestorovic
Natasa Nestorovic
NVNataša Veličković
Nataša Veličković
Danijela Vojnović MilutinovićDanijela Vojnović Milutinović
Danijela Vojnović Milutinović
Ana DjordjevicAna Djordjevic
Ana Djordjevic

1 June 2019 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Open access
BŠBranka Šošić-Jurjević
Branka Šošić-Jurjević
DLD. Lütjohann
D. Lütjohann
KRK. Renko
K. Renko
BFBranko R. Filípović
Branko R. Filípović
NRN. Radulović
N. Radulović
VMV. Milošević
V. Milošević
We examined whether isoflavones interfere with thyroid homeostasis, increase hepatic thyroid hormone concentrations and affect cholesterol metabolism in middle-aged (MA) male rats. Thirteen-month-old Wistar rats were injected subcutaneously with 35 mg/kg b.w./day of genistein, daidzein or vehicle (controls) for four weeks. Hepatic Dio1 gene expression was up-regulated by 70% (p < 0.001 for both) and Dio1 enzyme activity increased by 64% after genistein (p < 0.001) and 73% after daidzein treatment (p < 0.0001). Hepatic T3 was 75% higher (p < 0.05 for both), while T4 increased only after genistein treatment. Serum T4 concentrations were 31% lower in genistein- and 49% lower in dadzein-treated rats (p < 0.001 for both) compared with controls. Hepatic Cyp7a1 gene expression was up-regulated by 40% after genistein and 32% after daidzein treatment (p < 0.05 for both), in agreement with a 7α-hydroxycholesterol increase of 50% (p < 0.01) and 88% (p < 0.001), respectively. Serum 24- and 27-hydroxycholesterol were 30% lower (p < 0.05 for both), while only 24-hydroxycholesterol was decreased in the liver by 45% after genistein (p < 0.05) and 39% (p < 0.01) after dadzein treatment. Serum concentration of the cholesterol precursor desmosterol was 32% (p < 0.05) lower only after dadzein treatment alone, while both isoflavones elevated this parameter in the liver by 45% (p < 0.01). In conclusion, isoflavones increased T3 availability in the liver of MA males, despite decreasing serum T4. Hepatic increase of T3 possibly contributes to activation of the neutral pathway of cholesterol degradation into bile acids in the liver. While isoflavones obviously have the potential to trigger multiple mechanisms involved in cholesterol metabolism and oxysterol production, they failed to induce any hypocholesterolemic effect.

1 June 2013 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
BBBiljana N. Bursać
Biljana N. Bursać
Ana DjordjevicAna Djordjevic
Ana Djordjevic
AVAna D. Vasiljević
Ana D. Vasiljević
DMDanijela D. Vojnović Milutinović
Danijela D. Vojnović Milutinović
NVNataša Veličković
Nataša Veličković
GMGordana Matić
Gordana Matić

1 January 2015 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
MNMarina Nikolić
Marina Nikolić
DMDjuro Macut
Djuro Macut
Ana DjordjevicAna Djordjevic
Ana Djordjevic
NVNataša Veličković
Nataša Veličković
NNNatasa Nestorovic
Natasa Nestorovic
Danijela Vojnović MilutinovićDanijela Vojnović Milutinović
Danijela Vojnović Milutinović

28 August 2012 in Microscopy Research and Technique
Verified
Journal Article
Closed access
PDF file
IMIvana Medigović
Ivana Medigović
NRNataša Ristić
Nataša Ristić
STSvetlana Trifunović
Svetlana Trifunović
MMMilica Manojlović-Stojanoski
Milica Manojlović-Stojanoski
VMVerica Milošević
Verica Milošević
NNNatasa Nestorovic
Natasa Nestorovic

1 January 2005 in Hormone Research in Paediatrics
Verified
Journal Article
Closed access
BŠBranka Šošić-Jurjević
Branka Šošić-Jurjević
BFBranko R. Filípović
Branko R. Filípović
VMVerica Milošević
Verica Milošević
NNNatasa Nestorovic
Natasa Nestorovic
MMMilica Manojlović-Stojanoski
Milica Manojlović-Stojanoski
MSMilka Sekulić
Milka Sekulić
Objectives: In human medicine, estrogen is applied in prevention and treatment of health problems associated with the menopause. The aim of this study was to examine the effects of chronic estradiol dipropionate (EDP) treatment on thyroid gland structure and function in middle-aged female rats. Methods: At 14 months of age, Wistar rats received 0.625 mg EDP/kg b.w./day intraperitoneally for 2 weeks. The peripheral and central zones of the thyroid were stereologically analyzed and the following morphometric parameters determined: volume density of follicles, follicular epithelium, interstitium and colloid, epithelial height and the index of activation rate. Serum levels of TSH, T4 and T3 were determined by ELISA. Results: EDP treatment led to significant decreases in volume densities of follicles and follicular epithelium, epithelial height and index of activation rate (by 11%, p < 0.05; 23%, p < 0.005; 11%, p < 0.05 and 21%, p < 0.05, respectively) in comparison to control values. Hyperplasia of thyroid follicular cells was noticed in 25% of EDP-treated animals. Serum levels of T4 and T3 were decreased (by 33%, p < 0.005 and 28%, p < 0.001, respectively), but TSH concentration was not significantly different from that of the controls. Conclusion: Chronic estradiol treatment significantly decreased volume density and height of centrally located follicular epithelium, follicular activation index and serum level of total thyroid hormones in middle-aged rats.